B. Metzler seel. Sohn & Co. AG
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1847838
FRANKFURT, 2M
Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$228,198,014
-$5,404,339 QoQ
Shares Held
511,036
-0.8% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
2.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 7.909227529958751.ToString("F0")%
Shared 0.ToString("F0")%
None 92.09077247004124.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026B. Metzler seel. Sohn & Co. AG holds $257,562,391 across 18 Biotechnology names. VRTX ranks #1 (88.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
511,036 | $228,198,014 | |
| 2 | INSM |
INSMED Inc
|
39,243 | $6,417,014 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,475 | $2,804,122 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,252 | $2,512,624 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
112,300 | $2,156,160 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
26,338 | $1,651,392 | |
| 7 | TECH |
BIO-TECHNE Corp
|
31,091 | $1,624,815 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
9,241 | $1,561,913 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $228,198,014 | 511,036 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $233,602,353 | 515,269 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $123,531,871 | 315,422 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $142,295,268 | 319,621 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $152,399,771 | 314,343 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $32,521,649 | 80,759 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $18,599,943 | 39,993 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $16,515,348 | 35,235 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,494,202 | 15,536 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,347,483 | 15,600 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,628,518 | 16,186 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,489,795 | 15,600 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,662,752 | 17,973 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $5,861,944 | 20,299 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,947,222 | 23,994 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,548,235 | 23,238 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,103,044 | 23,386 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $5,119,973 | 23,315 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||